The results indicate that, unlike other inflammatory biomarkers of COVID-19 (i.e., hsTrop, C-reactive protein, D-dimer, and ferritin), sLRP1 displays a biphasic response in COVID-19. This evidence concerns the gene CRP and COVID-19.